Frazier Healthcare Partners was founded in 1991 as one of the first healthcare-focused investment firms. The firm has partnered with entrepreneurs in all stages of company growth, from company creation and venture capital to growth buyouts and leveraged recapitalizations. Frazier’s experienced team takes an active approach to helping build portfolio companies, leveraging the team’s deep domain expertise and expansive, global network of healthcare executives, advisors, and industry thought leaders.

Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing scientific ideas and actively build collaborative working relationships with companies to bring new science to patients faster. The Alpine BioVentures team leverages decades of experience and strong relationships with leading research labs and corporate partners in the United States and around the world to grow a portfolio of companies with the potential to help people living with cancer, autoimmune conditions and orphan diseases. The company’s portfolio includes Alpine Immune Sciences and Alpine Biosciences, which was acquired by Oncothyreon in 2014.

Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.